Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anemia, Aplastic | 2 | 2019 | 226 | 0.830 |
Why?
|
Lymphoma, Primary Cutaneous Anaplastic Large Cell | 1 | 2018 | 9 | 0.680 |
Why?
|
Kaposi Varicelliform Eruption | 1 | 2018 | 47 | 0.650 |
Why?
|
Hepatitis E | 1 | 2017 | 76 | 0.540 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2017 | 142 | 0.520 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2019 | 627 | 0.510 |
Why?
|
Hematologic Diseases | 2 | 2010 | 498 | 0.480 |
Why?
|
Mycosis Fungoides | 2 | 2012 | 163 | 0.420 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2019 | 1379 | 0.410 |
Why?
|
Thrombocytopenia | 3 | 2006 | 1171 | 0.390 |
Why?
|
Skin Neoplasms | 8 | 2021 | 5662 | 0.390 |
Why?
|
Hematologic Agents | 1 | 2010 | 39 | 0.360 |
Why?
|
Biological Products | 1 | 2018 | 856 | 0.350 |
Why?
|
Glioblastoma | 1 | 2019 | 3456 | 0.240 |
Why?
|
Medical Oncology | 2 | 2022 | 2235 | 0.220 |
Why?
|
Adenovirus E1A Proteins | 2 | 2000 | 76 | 0.210 |
Why?
|
Myasthenia Gravis | 1 | 2024 | 201 | 0.200 |
Why?
|
Kanamycin Kinase | 2 | 1998 | 34 | 0.200 |
Why?
|
Neoplasms, Adnexal and Skin Appendage | 1 | 2021 | 25 | 0.190 |
Why?
|
Heparin | 2 | 2006 | 1636 | 0.190 |
Why?
|
Myositis | 1 | 2024 | 251 | 0.190 |
Why?
|
Lymphomatoid Papulosis | 1 | 2000 | 16 | 0.190 |
Why?
|
Blood Coagulation Disorders | 1 | 2003 | 337 | 0.190 |
Why?
|
Hematology | 1 | 2023 | 219 | 0.180 |
Why?
|
Melanoma | 1 | 2018 | 5462 | 0.180 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2000 | 374 | 0.170 |
Why?
|
Critical Illness | 2 | 2003 | 2665 | 0.170 |
Why?
|
Brain Neoplasms | 1 | 2019 | 8829 | 0.160 |
Why?
|
Disabled Persons | 4 | 2008 | 1209 | 0.160 |
Why?
|
Fatal Outcome | 3 | 2019 | 1849 | 0.160 |
Why?
|
Quality of Health Care | 1 | 2013 | 4369 | 0.150 |
Why?
|
Blood Transfusion | 1 | 2003 | 1296 | 0.150 |
Why?
|
Gene Rearrangement | 2 | 2000 | 1179 | 0.140 |
Why?
|
Pentosyltransferases | 1 | 1996 | 65 | 0.140 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2021 | 701 | 0.140 |
Why?
|
Career Choice | 1 | 2022 | 743 | 0.140 |
Why?
|
Electronic Health Records | 1 | 2013 | 4440 | 0.140 |
Why?
|
DNA Helicases | 1 | 2000 | 861 | 0.130 |
Why?
|
Lichen Planus | 1 | 2015 | 57 | 0.120 |
Why?
|
Adenoviridae | 1 | 1998 | 1096 | 0.120 |
Why?
|
Medicare | 6 | 2008 | 6532 | 0.120 |
Why?
|
Incidental Findings | 1 | 2019 | 688 | 0.120 |
Why?
|
Fellowships and Scholarships | 1 | 2022 | 1066 | 0.120 |
Why?
|
Anemia | 1 | 2003 | 1499 | 0.120 |
Why?
|
Mycophenolic Acid | 1 | 1996 | 343 | 0.120 |
Why?
|
Oncolytic Virotherapy | 1 | 2018 | 490 | 0.110 |
Why?
|
Herpesvirus 1, Human | 1 | 2018 | 742 | 0.110 |
Why?
|
Lymphatic Metastasis | 1 | 2021 | 2906 | 0.110 |
Why?
|
Gene Deletion | 1 | 2000 | 2751 | 0.110 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2020 | 4029 | 0.110 |
Why?
|
Critical Care | 1 | 2003 | 2640 | 0.100 |
Why?
|
Oncology Service, Hospital | 1 | 1991 | 57 | 0.100 |
Why?
|
Phosphotransferases | 1 | 1992 | 309 | 0.090 |
Why?
|
Anticoagulants | 1 | 2006 | 4595 | 0.090 |
Why?
|
Lymphoma, T-Cell | 2 | 2004 | 299 | 0.090 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2000 | 1377 | 0.090 |
Why?
|
Social Security | 2 | 2007 | 100 | 0.090 |
Why?
|
3T3 Cells | 3 | 1998 | 1101 | 0.090 |
Why?
|
Mastectomy | 2 | 2008 | 1789 | 0.080 |
Why?
|
Neoplasms | 4 | 2010 | 21596 | 0.080 |
Why?
|
Clinical Competence | 1 | 2023 | 4681 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2015 | 2940 | 0.080 |
Why?
|
Aged, 80 and over | 4 | 2024 | 57683 | 0.070 |
Why?
|
Humans | 29 | 2024 | 742088 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2024 | 9185 | 0.070 |
Why?
|
Gentamicins | 2 | 1998 | 253 | 0.070 |
Why?
|
Acute Disease | 1 | 2017 | 7141 | 0.070 |
Why?
|
Medical Informatics | 1 | 2013 | 742 | 0.070 |
Why?
|
Oncogenes | 1 | 1992 | 1263 | 0.070 |
Why?
|
SEER Program | 5 | 2008 | 1507 | 0.070 |
Why?
|
Kidney Transplantation | 1 | 2020 | 4246 | 0.070 |
Why?
|
Male | 14 | 2024 | 349538 | 0.060 |
Why?
|
Complement Inactivating Agents | 1 | 2024 | 50 | 0.060 |
Why?
|
Restriction Mapping | 2 | 1996 | 878 | 0.060 |
Why?
|
Transfection | 3 | 1998 | 5892 | 0.060 |
Why?
|
Methyltransferases | 1 | 2006 | 367 | 0.060 |
Why?
|
Patient Admission | 1 | 1991 | 1380 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2013 | 2749 | 0.050 |
Why?
|
Prednisone | 2 | 2024 | 1567 | 0.050 |
Why?
|
Cell Division | 3 | 2000 | 4564 | 0.050 |
Why?
|
Reed-Sternberg Cells | 1 | 2001 | 73 | 0.050 |
Why?
|
Erythropoietin | 1 | 2006 | 724 | 0.050 |
Why?
|
Mastectomy, Segmental | 1 | 2006 | 955 | 0.050 |
Why?
|
Hemostasis | 1 | 2003 | 458 | 0.050 |
Why?
|
Pityriasis Lichenoides | 1 | 2000 | 6 | 0.050 |
Why?
|
HELLP Syndrome | 1 | 2000 | 41 | 0.050 |
Why?
|
Education, Medical, Graduate | 2 | 2023 | 2283 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 1991 | 1952 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8621 | 0.050 |
Why?
|
Accreditation | 1 | 2023 | 449 | 0.050 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2000 | 110 | 0.040 |
Why?
|
North America | 1 | 2023 | 1249 | 0.040 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2000 | 188 | 0.040 |
Why?
|
Lymph Node Excision | 2 | 2021 | 1248 | 0.040 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 2000 | 131 | 0.040 |
Why?
|
Mohs Surgery | 1 | 2021 | 197 | 0.040 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2000 | 169 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2008 | 5171 | 0.040 |
Why?
|
Genetic Complementation Test | 1 | 1998 | 561 | 0.040 |
Why?
|
Methotrexate | 1 | 2004 | 1720 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 1992 | 7721 | 0.040 |
Why?
|
Attitude to Death | 1 | 2000 | 382 | 0.040 |
Why?
|
Platelet Transfusion | 1 | 2000 | 314 | 0.040 |
Why?
|
Clone Cells | 2 | 2001 | 1692 | 0.040 |
Why?
|
Hygromycin B | 1 | 1996 | 11 | 0.040 |
Why?
|
Puromycin | 1 | 1996 | 44 | 0.040 |
Why?
|
Cell Size | 1 | 1998 | 643 | 0.040 |
Why?
|
Leiomyosarcoma | 1 | 2000 | 477 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2000 | 2837 | 0.030 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1996 | 192 | 0.030 |
Why?
|
Diagnosis, Differential | 4 | 2015 | 12958 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 1992 | 8425 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2000 | 1866 | 0.030 |
Why?
|
Physicians | 1 | 2013 | 4554 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 2000 | 4322 | 0.030 |
Why?
|
Survival Rate | 3 | 2021 | 12773 | 0.030 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2000 | 986 | 0.030 |
Why?
|
Remission Induction | 1 | 2000 | 2384 | 0.030 |
Why?
|
Lung Neoplasms | 4 | 2008 | 13019 | 0.030 |
Why?
|
Mass Screening | 1 | 2010 | 5238 | 0.030 |
Why?
|
Colonic Neoplasms | 2 | 2000 | 2542 | 0.030 |
Why?
|
Sequence Deletion | 1 | 1998 | 1526 | 0.030 |
Why?
|
RNA Splicing | 1 | 1998 | 907 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2012 | 11472 | 0.030 |
Why?
|
Hodgkin Disease | 1 | 2001 | 1413 | 0.030 |
Why?
|
Breast Neoplasms | 4 | 2008 | 20774 | 0.030 |
Why?
|
POEMS Syndrome | 1 | 1992 | 19 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2004 | 4414 | 0.030 |
Why?
|
Neoplasm Staging | 4 | 2008 | 11001 | 0.030 |
Why?
|
Healthcare Disparities | 1 | 2008 | 3151 | 0.030 |
Why?
|
Base Sequence | 2 | 2001 | 12797 | 0.030 |
Why?
|
Brain | 1 | 2019 | 26343 | 0.030 |
Why?
|
Cell Line | 2 | 2000 | 15994 | 0.030 |
Why?
|
Survival Analysis | 2 | 2008 | 10248 | 0.030 |
Why?
|
Aged | 8 | 2021 | 162944 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 1998 | 1782 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2008 | 1769 | 0.030 |
Why?
|
Lymphoma | 1 | 2000 | 1873 | 0.030 |
Why?
|
Telangiectasis | 1 | 1991 | 75 | 0.020 |
Why?
|
Blotting, Southern | 1 | 1992 | 803 | 0.020 |
Why?
|
Health Services Research | 2 | 2007 | 1834 | 0.020 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2004 | 1130 | 0.020 |
Why?
|
Pre-Eclampsia | 1 | 2000 | 1196 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2001 | 18112 | 0.020 |
Why?
|
Female | 12 | 2021 | 379592 | 0.020 |
Why?
|
Catastrophic Illness | 1 | 1991 | 57 | 0.020 |
Why?
|
Adult | 7 | 2017 | 213712 | 0.020 |
Why?
|
Recurrence | 2 | 2000 | 8333 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6534 | 0.020 |
Why?
|
Retrospective Studies | 6 | 2021 | 77098 | 0.020 |
Why?
|
Mice | 4 | 2000 | 81045 | 0.020 |
Why?
|
Drug Resistance | 1 | 1996 | 1608 | 0.020 |
Why?
|
Fees and Charges | 1 | 1991 | 195 | 0.020 |
Why?
|
Primary Myelofibrosis | 1 | 1991 | 214 | 0.020 |
Why?
|
Mastocytosis | 1 | 1991 | 160 | 0.020 |
Why?
|
Middle Aged | 9 | 2024 | 213127 | 0.020 |
Why?
|
Diagnosis-Related Groups | 1 | 1991 | 454 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 1998 | 7153 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 2000 | 1820 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2000 | 13814 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2000 | 2211 | 0.020 |
Why?
|
Terminal Care | 1 | 2000 | 1688 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2006 | 15530 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 1992 | 1586 | 0.020 |
Why?
|
United States | 6 | 2008 | 69693 | 0.020 |
Why?
|
Decision Making | 1 | 2000 | 3869 | 0.020 |
Why?
|
Genotype | 1 | 2000 | 12946 | 0.020 |
Why?
|
Gene Expression | 1 | 1998 | 7790 | 0.020 |
Why?
|
Marital Status | 1 | 2007 | 437 | 0.020 |
Why?
|
Health Maintenance Organizations | 1 | 2008 | 642 | 0.020 |
Why?
|
Animals | 4 | 2000 | 168561 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2000 | 4249 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5304 | 0.020 |
Why?
|
Health Resources | 1 | 1991 | 911 | 0.020 |
Why?
|
Risk Assessment | 2 | 2021 | 23320 | 0.020 |
Why?
|
Escherichia coli | 1 | 1996 | 4214 | 0.010 |
Why?
|
RNA, Messenger | 1 | 1998 | 13029 | 0.010 |
Why?
|
Risk Factors | 1 | 2010 | 72145 | 0.010 |
Why?
|
Gastritis | 1 | 2004 | 191 | 0.010 |
Why?
|
Fee-for-Service Plans | 1 | 2008 | 694 | 0.010 |
Why?
|
Phenotype | 1 | 2000 | 16331 | 0.010 |
Why?
|
Vincristine | 1 | 2004 | 1036 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2000 | 12071 | 0.010 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 2001 | 43 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2001 | 335 | 0.010 |
Why?
|
Pneumonectomy | 1 | 2008 | 1093 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2008 | 1827 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2001 | 1086 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2008 | 3471 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2004 | 2236 | 0.010 |
Why?
|
Pregnancy | 1 | 2000 | 29087 | 0.010 |
Why?
|
Cytomegalovirus Infections | 1 | 2004 | 817 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2001 | 11363 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 53187 | 0.010 |
Why?
|
Cause of Death | 1 | 2006 | 3571 | 0.010 |
Why?
|
Disease Progression | 2 | 2004 | 13256 | 0.010 |
Why?
|
Palliative Care | 1 | 1991 | 3478 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2000 | 1284 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12242 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2008 | 7770 | 0.010 |
Why?
|
Mutation | 1 | 1998 | 29717 | 0.010 |
Why?
|
Comorbidity | 1 | 2008 | 10372 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2008 | 12344 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2000 | 6313 | 0.010 |
Why?
|
Registries | 1 | 2008 | 8077 | 0.010 |
Why?
|
NF-kappa B | 1 | 2000 | 2500 | 0.010 |
Why?
|
Crohn Disease | 1 | 2004 | 2301 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 1992 | 11690 | 0.010 |
Why?
|
Heart Diseases | 1 | 2004 | 2789 | 0.010 |
Why?
|
Age Factors | 1 | 2008 | 18355 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2000 | 2414 | 0.010 |
Why?
|
Data Collection | 1 | 2000 | 3339 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2001 | 3465 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2000 | 4839 | 0.010 |
Why?
|
Young Adult | 1 | 2015 | 56350 | 0.010 |
Why?
|
Emotions | 1 | 2000 | 2657 | 0.000 |
Why?
|
Skin | 1 | 2001 | 4353 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2008 | 39004 | 0.000 |
Why?
|
Cohort Studies | 1 | 2006 | 40450 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2008 | 62966 | 0.000 |
Why?
|
Hospitalization | 1 | 2000 | 10232 | 0.000 |
Why?
|
Prognosis | 1 | 2000 | 29010 | 0.000 |
Why?
|
Quality of Life | 1 | 2000 | 12730 | 0.000 |
Why?
|
Signal Transduction | 1 | 2000 | 23387 | 0.000 |
Why?
|